The Resource Has BEPS signaled the death knell for U.S. pharmaceutical IP migration to Ireland?

Has BEPS signaled the death knell for U.S. pharmaceutical IP migration to Ireland?

Label
Has BEPS signaled the death knell for U.S. pharmaceutical IP migration to Ireland?
Title
Has BEPS signaled the death knell for U.S. pharmaceutical IP migration to Ireland?
Creator
Subject
Language
eng
Summary
Mergers and acquisitions continue to flourish within the pharmaceutical industry. Are multinational pharmaceutical enterprises still able to generate tax savings through IP migration to Ireland, in light of the OECD action plan to combat base erosion and profit shifting?
Citation source
In: Tax planning international review. - London. - Vol. 43 (2016), no. 5 ; 3 p
http://library.link/vocab/creatorName
  • Alms, M
  • Taylor, K
  • Donnelly, C
Geographic coverage
  • European Union
  • Europe
Language note
English
http://library.link/vocab/subjectName
  • BEPS
  • intangibles
  • merger
  • acquisition
  • pharmaceutical industry
Label
Has BEPS signaled the death knell for U.S. pharmaceutical IP migration to Ireland?
Instantiates
Publication
Label
Has BEPS signaled the death knell for U.S. pharmaceutical IP migration to Ireland?
Publication

Library Locations

    • IBFD Library AmsterdamBorrow it
      Rietlandpark 301, Amsterdam, 1019 DW, NL
      52.3736660 4.9336932
Processing Feedback ...